Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001846487-26-000004

HEAD OF RARE DISEASE sold 7,032 shares at $76.55 ($538,300)

  • HEAD OF RARE DISEASE gave up 5,576 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mutz Christopher · HEAD OF RARE DISEASE

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Shares withheld for taxes : show line 1 in the form 10b5-1 −3,173 $76.70 $243,369 99,598 D
2026-02-12 Sale : show line 2 in the form 10b5-1 −7,032 $76.55 $538,300 92,566 D
2026-02-14 Shares withheld for taxes : show line 3 in the form 10b5-1 −2,403 $77.36 $185,896 90,163 D
Open-market sales · 7,032 sh · avg $76.55 · $538,300
Loading xslF345X05/wk-form4_1771362479.xml…